Marty Makary, M.D., M.P.H., as FDA administrator may be the least controversial of Trump's picks for the top healthcare jobs so far.
President-Elect Donald Trump named his picks for FDA administrator, CDC director and Surgeon General late Friday evening, leaving only the directorship of the National Institutes of Health (NIH) as the only unfilled slot among six most prominent healthcare jobs in the federal government. Several news outlets have identified Jay Bhattacharya, M.D.,Ph.D., a Stanford University professor, as Trump’s likely pick for NIH director.
Marty Makary, M.D., M.P.H.
The selection of Marty Makary, M.D., M.P.H., could be Trump’s least controversial healthcare pick so far. Makary is a surgeon at Johns Hopkins, a member of the National Academy of Medicine and a prolific writer of both journal articles and books on healthcare for the general public.
Stat quoted Jerome Adams, the surgeon general in the first Trump administration, as saying, “I think Marty Makary is a reasonable pick to lead the FDA and perhaps the least surprising or controversial of Trump’s health picks so far”
Trump’s pick for CDC director is Dave Weldon, M.D., an internist who served seven terms in Congress representing the so-called Space Coast district along central Florida Atlantic Coast. Weldon has said he got into politics because of his pro-life views and the eponymous Weldon Administration bars HHS funding from going to programs that discriminate against healthcare insurers or providers who refuseto pay for or provide abortions.
According to the Washington Post, Weldon was one of the few members of Congress to give credence to the theory that vaccines cause autism, and he pushed to have thimerosal removed from flu shots.
Janette Nesheiwat, M.D., the pick for Surgeon General, is a Fox News medical contributor and has appeared on other television shows. Her book, “Beyond the Stethoscope: Miracles in Medicine,” is described on her website as a “vivid Christain memoir” that follows a young doctor from a humble immigrant family. Nesheiwat sells a vitamin and mineral supplement, B+C Boost containing vitamins C, B12, and D3 and zinc on her website that is marketed as strengthening the immune system. Her picture is on the bottle.
The Friday night announcement of the Makary, Weldon and Nesheiwat selections came after Trump announced on Nov. 19 that he wanted Mehmet Oz, M.D., the famous television show doctors and 2022 Republican Senate candidate in Pennsylvania, to serve as CMS administrator and after the Nov. 14 announcement that Robert F. Kennedy Jr. was his pick for HHS secretary.
HHS is the umbrella agency for the FDA, CDC, FDA, the Office of the Surgeon General and NIH.Unless there are maneuvers to use recess appointments to bypass the Senate, all six positions require confirmation by the Senate by a simple majority vote. The Republicans are expected to have 53-47 majority in next year’s Congress.
Because of his views questioning the proof for vaccine safety and efficacy, Kennedy has been most the controversial of Trump’s healthcare. Weldon will also come under scrutiny because of his positions on vaccines and autism. The CDC doesn’t have much authority over issues affecting abortion services and rights, but his strong pro-life positions may also stir up opposition. Oz’s immensely popular “The Dr. Oz Show” focused mainly on personal health issues, but he talked up Medicare Advantage on his show and the Better Medicare Alliance, a Medicare Advantage trade group, issued a positive statement after his selection became public.
Optimize Your Healthcare Payments with Optum Financial
April 29th 2025Discover how Optum Financial is revolutionizing healthcare payments in our latest whitepaper. Learn how transitioning to electronic payments can reduce administrative costs, streamline claims processing and enhance security.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Healthcare hasn't been a priority of the second Trump administration so far, panelists at the Asembia agreed. Medicaid may loom large, though, as the administration and congressional Republicans look for ways to slash government spending as a way of offsetting major tax cuts.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
What 5 Managed Care Trends Experts Say You’re Not Watching Closely Enough
April 29th 2025Managed Healthcare Executive asked several experts in healthcare and managed care two share the trends they think the industry is overlooking. From rising costs and data challenges to shifts in how care is delivered, these are the issues that could have a major impact — and deserve a closer look.
Read More